Aprea Therapeutics, Inc. (APRE) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 47.25M | 15.56M | 13.94M | 16.93M | 19.83M | 23.58M | 26.48M | 29.56M | 33.07M | 22.52M | 25.64M | 28.64M |
| Cash & Short-Term Investments | 46.47M | 14.6M | 13.72M | 16.53M | 19.28M | 22.85M | 26.25M | 28.69M | 32.37M | 21.61M | 25.35M | 27.69M |
| Cash Only | 46.47M | 14.6M | 13.72M | 16.53M | 19.28M | 22.85M | 26.25M | 28.69M | 32.37M | 21.61M | 25.35M | 27.69M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 779.24K | 961.9K | 225.94K | 395.01K | 558.69K | 726.25K | 234.19K | 865.09K | 698.86K | 914.27K | 286.26K | 953.67K |
| Total Non-Current Assets | 866.95K | 372.15K | 377.33K | 382.5K | 387.67K | 403.35K | 410.15K | 404.8K | 131.17K | 129.08K | 126.65K | 41.87K |
| Property, Plant & Equipment | 54.38K | 59.81K | 65.24K | 70.67K | 76.09K | 81.52K | 86.95K | 92.38K | 90.18K | 88.36K | 86.2K | 1.69K |
| Fixed Asset Turnover | - | - | - | 1.61x | 2.06x | 2.44x | 3.95x | 6.15x | 4.26x | 0.16x | 7.27x | 138.75x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 541.4K | 0 | 40.93K | 0 | 40.42K | 40.17K | 0 | 41.26K | 0 | 40.72K | 0 | 0 |
| Other Non-Current Assets | 271.16K | 312.35K | 271.16K | 311.83K | 271.16K | 281.66K | 323.2K | 271.16K | 40.99K | 0 | 40.45K | 40.18K |
| Total Assets | 48.11M | 15.93M | 14.32M | 17.31M | 20.22M | 23.98M | 26.89M | 29.96M | 33.2M | 22.65M | 25.77M | 28.68M |
| Asset Turnover | - | - | - | 0.01x | 0.01x | 0.01x | 0.01x | 0.02x | 0.01x | 0.00x | 0.01x | 0.01x |
| Asset Growth % | 137.92% | -33.55% | -46.75% | -42.23% | -39.09% | 5.87% | 4.38% | 4.48% | 3.68% | -24.89% | -23.36% | -29.5% |
| Total Current Liabilities | 5.3M | 2.76M | 2.68M | 3.17M | 3.36M | 3.36M | 3.64M | 3.09M | 2.97M | 4.39M | 4.17M | 3.95M |
| Accounts Payable | 2.94M | 713.67K | 641.32K | 1.2M | 1.28M | 1.35M | 1.15M | 964.33K | 1.32M | 1.67M | 862.55K | 1.13M |
| Days Payables Outstanding | 30.3K | - | - | 58.95 | 47.73 | 48.87 | 34.23 | 40.61 | 84.97 | 56.96 | 43.21 | 40.43 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 50.74K | 148.41K | 528.97K | 0 | 0 |
| Other Current Liabilities | 1.78M | 770.56K | 1.45M | 420.64K | 388.97K | 465.01K | 673.32K | 1.5M | 285.21K | 1.17M | 1.04M | 1.28M |
| Current Ratio | 8.92x | 5.63x | 5.20x | 5.34x | 5.90x | 7.01x | 7.28x | 9.55x | 11.15x | 5.14x | 6.15x | 7.25x |
| Quick Ratio | 8.92x | 5.63x | 5.20x | 5.34x | 5.90x | 7.01x | 7.28x | 9.55x | 11.15x | 5.14x | 6.15x | 7.25x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 727.36K | 0 | 727.36K | 1.31M | 1.31M | 1.31M | 1.31M | 1.31M | 1.31M | 1.31M | 1.31M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 727.36K | 0 | 727.36K | 1.31M | 1.31M | 1.31M | 1.31M | 1.31M | 1.31M | 1.31M | 1.31M |
| Total Liabilities | 5.3M | 3.49M | 2.68M | 3.9M | 4.67M | 4.67M | 4.95M | 3.09M | 4.28M | 4.39M | 5.48M | 5.26M |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Debt | -46.47M | -14.6M | -13.72M | -16.53M | -19.28M | -22.85M | -26.25M | -28.69M | -32.37M | -21.61M | -25.35M | -27.69M |
| Debt / Equity | - | - | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 42.82M | 12.44M | 11.64M | 13.41M | 15.55M | 19.31M | 21.95M | 26.87M | 28.92M | 18.26M | 20.29M | 23.42M |
| Equity Growth % | 175.34% | -35.56% | -46.96% | -50.08% | -46.24% | 5.71% | 8.17% | 14.74% | 9.22% | -28.78% | -23.8% | 165.46% |
| Book Value per Share | 5.57 | 1.62 | 1.83 | 2.21 | 2.59 | 3.24 | 3.69 | 4.53 | 6.89 | 4.89 | 5.43 | 6.28 |
| Total Shareholders' Equity | 42.82M | 12.44M | 11.64M | 13.41M | 15.55M | 19.31M | 21.95M | 26.87M | 28.92M | 18.26M | 20.29M | 23.42M |
| Common Stock | 11.98K | 8.19K | 5.98K | 5.75K | 5.51K | 5.48K | 5.43K | 5.43K | 5.43K | 3.74K | 3.74K | 3.73K |
| Retained Earnings | -336.93M | -333.64M | -331.19M | -328.21M | -324.97M | -321.04M | -318.15M | -314.36M | -310.89M | -308.08M | -304.64M | -301.44M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -10.63M | -10.63M | -10.63M | -10.63M | -10.63M | -10.63M | -10.6M | -10.63M | -10.63M | -10.61M | -10.64M | -10.63M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |